We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warning Letter Leads Eksa Mills to Stop Production at Mexico Plant
FDA Warning Letter Leads Eksa Mills to Stop Production at Mexico Plant
Eksa Mills has stopped drug manufacturing activities at its Puebla, Mexico, facility in the wake of an FDA warning letter that cites the company’s quality unit for failure to properly oversee the manufacture of drug products.